Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Interim Management Statement

19 May 2008 07:00

Chesnara plc

Interim Management Statement for the period from1 January 2008 to 16 May 2008

19 May 2008

This statement relates primarily to the financial position of Chesnara plc (the "Group") as at 31 March 2008 and to its financial performance during the first quarter. Where events and transactions have occurred since the first quarter end, which are estimated to have a material impact on management's core expectation of the financial position and/or financial performance of the Group, then these are identified together with a broad indication of their impact.

The key determinant of Group performance in the first quarter was the decline in global equity markets with the leading UK market indices showing an 11% decline over that period. The effect of this was a ‚£5m net of tax reduction to European Embedded Value ("EEV"). However subsequent recovery, particularly in the UK where markets have gained some 9% since the quarter end (to 16 May), implies a net of tax reduction in EEV over the whole period, due to investment market fluctuations, of some ‚£0.9m.

Apart from the impact of poor equity market performance in the first quarter the business is, based on fundamentals, performing slightly ahead of expectations. Key contributors are:

* Continuing favourable lapse experience across both our key protection and endowment products, offset by slightly higher mortality experience, which led to a net of tax EEV increase of some ‚£1m in the first quarter; * Endowment misselling complaints continue at relatively low levels with no significant change in uphold rates. Therefore the provision we hold continues to prove adequate; and * Expenses continue to be in line with management expectations.

The expected return from in-force business is also in line with expectations. The overall position at the quarter end is a reduction in EEV of some ‚£1.7m (net of tax) from ‚£187.3m to ‚£185.6m - both amounts are stated before adjustment for the proposed final dividend of ‚£10.3m. As indicated earlier, the market recovery since the quarter end has increased the EEV by some ‚£4.1m.

In contrast to the current volatility of the EEV, the IFRS result, which is impacted less by short-term market movements, of ‚£5.6m pre-tax (‚£4.7m net of tax) for the quarter has proved more resilient, and is broadly in line with management expectations.

The emergence of surplus from the life business has remained strong so that the ratio of regulatory capital resources to regulatory capital requirements in the life company has improved from 179% as at year-end to 206% at quarter end.

Whilst investment market performance has negatively affected the result to date this has been wholly mitigated by positive returns from other areas of the business.

The information in this release is based on management information.

Enquiries

Graham Kettleborough

Chief Executive, Chesnara Plc 07799 407519

Michael Henman

Cubitt Consulting 0207 367 5100

Notes to editors:

Chesnara plc, which listed on the London Stock Exchange in May 2004, is the owner of Countrywide Assured plc ("CA"). CA is a life assurance subsidiary that is substantially closed to new business. In June 2005 Chesnara acquired City of Westminster Assurance ("CWA") for ‚£47.8m. With effect from 30 June 2006, CWA's policies and assets were transferred into CA plc. Chesnara's operating model is to maintain a relatively small governance team and outsource the majority of its back office functions. Chesnara continues to seek acquisition opportunities in the financial services sector.

vendor
Date   Source Headline
13th May 20251:00 pmRNSSenior Independent Director Appointment
13th May 202512:44 pmRNSAGM Statement
1st May 20257:00 amRNSTotal Voting Rights
25th Apr 20257:00 amRNSBlock listing Interim Review
24th Apr 20257:00 amRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSNotice of AGM
7th Apr 202512:30 pmRNSApplication for Block Listing - Replacement
7th Apr 202512:09 pmRNSDirector/PDMR Shareholding
4th Apr 202512:00 pmRNSApplication for Block Listing
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20252:45 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
10th Mar 20251:41 pmRNSNotice of Results (Replacement)
10th Mar 20257:00 amRNSNotice of Results
30th Jan 20259:07 amRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSDirectorate Changes
23rd Dec 20247:00 amRNSAcquisition
12th Dec 202412:00 pmRNSDirector/PDMR Shareholding
22nd Nov 20241:55 pmRNSDirector/PDMR Shareholding
14th Nov 20242:06 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20247:00 amRNSBlock listing Interim Review
11th Sep 20247:00 amRNSDirector/PDMR Shareholding
10th Sep 20247:00 amRNSHalf-year Report
12th Aug 20249:00 amRNSNotice of Half Year Results
1st Aug 20247:00 amRNSDirector/PDMR Shareholding
18th Jul 20249:00 amRNSExternal Directorship
10th Jul 20249:00 amRNSHolding(s) in Company
7th Jun 202411:28 amRNSDirector/PDMR Shareholding
6th Jun 20243:30 pmEQSHardman Talks Video | Chesnara plc (CSN) Management Presentation and Q&A
16th May 20247:00 amRNSDirector/PDMR Shareholding
14th May 20242:15 pmRNSAGM Statement
9th May 20242:04 pmEQSQ&A on Chesnara plc (CSN): Growth and stability insights
30th Apr 20244:45 pmRNSDirector/PDMR Shareholding
26th Apr 20244:57 pmRNSDirector/PDMR Shareholding
25th Apr 202410:00 amRNSBlock listing Interim Review
17th Apr 202410:00 amRNSNotice of AGM
16th Apr 20241:00 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSDirectorate Change
11th Apr 202410:23 amEQSHardman & Co Research on Chesnara plc (CSN): Good 2023 results set platform for future progress
9th Apr 20244:58 pmRNSDirectorate Change
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
3rd Apr 20241:33 pmRNSDirector/PDMR Shareholding
28th Mar 202412:00 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSFinal Results
21st Mar 20247:45 amRNSDirector Declaration
14th Mar 202411:15 amRNSNotice of Results
29th Dec 202311:55 amRNSTotal Voting Rights
29th Dec 202311:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.